(Q42468260)

1 November 2017

Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: a study with monoclonal antibody (English)

1 reference

1 November 2017

Zhang PJ

1

1 reference

1 November 2017

Driscoll DL

2

1 reference

1 November 2017

Lee HK

3

1 reference

1 November 2017

Nolan C

4

1 reference

1 November 2017

Velagapudi SR

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

1 November 2017

1 reference

1 November 2017

30

1 reference

1 November 2017

2

1 reference

1 November 2017

168-172

1 reference

Inhibin structure and function in the testis

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990271-X

7 January 2021

Evidence for the prostatic origin of immunoreactive inhibin-like material in human seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990271-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990271-X

7 January 2021

Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP)

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990271-X

7 January 2021

Immunohistochemical localization of a prostatic secretory protein of 94 amino acids in normal prostatic tissue, in primary prostatic tumors and in their metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990271-X

7 January 2021

Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990271-X

7 January 2021

Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: comparison of its distribution in normal, benign and malignant prostates

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990271-X

7 January 2021

Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990271-X

7 January 2021

Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990271-X

7 January 2021

10.1016/S0046-8177(99)90271-X

Identifiers

DOI

1 reference

1 November 2017

1 reference